By Zeba Siddiqui MUMBAI (Reuters) - Ipca Laboratories Ltd has voluntarily halted shipments to the United States from one of its drug ingredient manufacturing plants after the U.S. Food and Drug Administration found violations of standard production practices ... Sify, 1 month ago
India's Ipca halts U.S. shipments from plant after FDA finds violations - Yahoo! Finance, 1 month ago
Ipca Halts U.S. Shipments From Plant After FDA Finds Violations - Medscape, 1 month ago
By Reuters -Ranbaxy Laboratories Ltd. (NSE:RANB) has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy ofNovartis (NYSE:NVS) blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans ...Investing.com, 2 months ago Ranbaxy to Make Generic Diovan Drug in US International Business Times India, 2 months ago FDA greenlights first generic Diovan blood pressure medicine in U.S. MedCity News, 2 months ago FDA approves Ranbaxy`s generic version of Novartis`s Diovan ZeeNews.com, 2 months ago
As marketing rights for off-patent drugs in the US become less exclusive, companies are scrambling for fresh strategies to make up for the revenue loss Sushmi Dey | New Delhi June 17, 2014 Last Updated at 23:50 IST Indian drug makers may have to ...Business Standard India, 2 months ago
on your WebpageAdd Widget >Get your members hooked!